Hyperliquid recently closed a significant long position covering 288.649 Bitcoin, valued at approximately $23.67 million when Bitcoin was priced at $82,008. This position is about 2.3 times larger than a previous long trade by Hyperliquid, which involved 121.23 BTC valued at $10.27 million and used 7x leverage, resulting in a $20,000 loss when closed. The move highlights Hyperliquid's substantial exposure and trading activity in Bitcoin, reflecting notable market engagement and risk management strategies.
Hyperliquid's recent Bitcoin long position of $23.7 million contrasts with smaller trades in the crypto market. For readers following cryptocurrency, here is Pluang's market snapshot as of Oct 17, 2026 01:31 WIB: out of 50 major cryptocurrencies, 19 rose and 30 fell today. Among notable movers, UNI dropped 3.32% to Rp128.298 with a typical hold time of 65 days and a 66% buy order activity, ADA fell 2.91% to Rp4.002 with 127 days hold time and 86% buy orders, while XRP declined 2.78% to Rp23.292 with 72 days hold time and a 57% sell order activity.
Kering has released its monthly statement detailing the total number of shares and voting rights as of October 15, 2026. The company reported 123,420,778 total shares and 176,815,752 theoretical voting rights, with 176,046,302 exercisable voting righ...
Kering published its monthly update on October 15, 2026, reporting a total of 123,420,778 shares composing its capital and 176,815,752 theoretical voting rights. The voting rights figure includes all shares with voting rights, including those tempora...
Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
